• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者的体重减轻及其对生活质量的影响。

Weight loss and impact on quality of life in Parkinson's disease.

作者信息

Akbar Umer, He Ying, Dai Yunfeng, Hack Nawaz, Malaty Irene, McFarland Nikolaus R, Hess Christopher, Schmidt Peter, Wu Samuel, Okun Michael S

机构信息

Department of Neurology, Brown University, Providence, Rhode Island, United States of America.

Department of Mathematics, Clarkson University, Potsdam, New York, United States of America.

出版信息

PLoS One. 2015 May 4;10(5):e0124541. doi: 10.1371/journal.pone.0124541. eCollection 2015.

DOI:10.1371/journal.pone.0124541
PMID:25938478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4418600/
Abstract

INTRODUCTION

Weight loss is common in Parkinson's Disease (PD) and sometimes may precede the diagnosis. Weight loss is associated with multiple factors but its impact on health-related quality of life (HRQL) in PD remains unknown. We sought to investigate the factors associated with weight change and to quantify its effect on HRQL.

METHODS

The National Parkinson Foundation Quality Improvement Initiative (NPF-QII) data was used to analyze PD patients longitudinally between two visits, separated by 12 ± 6 months. Multiple linear regression analyses were used to assess the associations between baseline covariates and body weight change per month, and to evaluate whether, and to what degree, Parkinson's Disease Questionnaire (PDQ-39) scores were affected.

RESULTS

A higher Hoehn & Yahr stage, higher number of comorbidities, older age, lower MOCA estimate, and higher rate of levodopa usage were observed in patients who lost weight. Multivariate regression analysis indicated that age and levodopa usage were significantly associated with weight loss. Furthermore, monthly body weight loss was significantly associated with HRQL decline in PD patients. Loss of 1 lb (0.45 kg) per month was associated with a decline in QOL: an increase of 0.5% in PDQ-39 Summary Index score (p=0.004), and 1.1% and 1.5% increases in the mobility and ADL dimensions, respectively.

CONCLUSION

Weight loss in PD is common and seems to correlate with worsened HRQL. Awareness of factors associated with weight loss and its relation to HRQL may help practitioners improve patient management and expectations.

摘要

引言

体重减轻在帕金森病(PD)中很常见,有时可能在诊断之前就出现。体重减轻与多种因素相关,但其对PD患者健康相关生活质量(HRQL)的影响尚不清楚。我们旨在研究与体重变化相关的因素,并量化其对HRQL的影响。

方法

使用国家帕金森基金会质量改进计划(NPF-QII)的数据对PD患者进行纵向分析,两次就诊间隔12±6个月。采用多元线性回归分析评估基线协变量与每月体重变化之间的关联,并评估帕金森病问卷(PDQ-39)评分是否受到影响以及受影响的程度。

结果

体重减轻的患者Hoehn&Yahr分期更高、合并症数量更多、年龄更大、蒙特利尔认知评估量表(MOCA)评分更低以及左旋多巴使用率更高。多变量回归分析表明,年龄和左旋多巴使用与体重减轻显著相关。此外,PD患者每月体重减轻与HRQL下降显著相关。每月体重减轻1磅(0.45千克)与生活质量下降相关:PDQ-39综合指数评分增加0.5%(p=0.004),运动和日常生活活动维度分别增加1.1%和1.5%。

结论

PD患者体重减轻很常见,并似乎与HRQL恶化相关。了解与体重减轻相关的因素及其与HRQL的关系可能有助于医生改善患者管理和预期。

相似文献

1
Weight loss and impact on quality of life in Parkinson's disease.帕金森病患者的体重减轻及其对生活质量的影响。
PLoS One. 2015 May 4;10(5):e0124541. doi: 10.1371/journal.pone.0124541. eCollection 2015.
2
Caregiver strain in Parkinson's disease: national Parkinson Foundation Quality Initiative study.帕金森病患者的照护者压力:国家帕金森基金会质量倡议研究。
Parkinsonism Relat Disord. 2013 Nov;19(11):975-9. doi: 10.1016/j.parkreldis.2013.06.015. Epub 2013 Jul 18.
3
Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data.帕金森病中的规律运动、生活质量和运动能力:对国家帕金森病基金会质量改进计划数据的纵向分析
J Parkinsons Dis. 2017;7(1):193-202. doi: 10.3233/JPD-160912.
4
Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.帕金森病非运动症状对健康相关和感知生活质量的影响。
J Neurol Sci. 2013 Sep 15;332(1-2):136-40. doi: 10.1016/j.jns.2013.07.005. Epub 2013 Jul 25.
5
Mobility, mood and site of care impact health related quality of life in Parkinson's disease.运动能力、情绪及护理地点会影响帕金森病患者与健康相关的生活质量。
Parkinsonism Relat Disord. 2014 Mar;20(3):274-9. doi: 10.1016/j.parkreldis.2013.10.004. Epub 2013 Oct 16.
6
Back to the basics: regular exercise matters in parkinson's disease: results from the National Parkinson Foundation QII registry study.回归基础:规律运动对帕金森病至关重要:美国国家帕金森病基金会第二季度登记研究结果
Parkinsonism Relat Disord. 2014 Nov;20(11):1221-5. doi: 10.1016/j.parkreldis.2014.09.008. Epub 2014 Sep 16.
7
Predictors and course of health-related quality of life in Parkinson's disease.帕金森病中与健康相关生活质量的预测因素及病程
Mov Disord. 2008 Jul 30;23(10):1420-7. doi: 10.1002/mds.22121.
8
What are the issues facing Parkinson's disease patients at ten years of disease and beyond? Data from the NPF-QII study.帕金森病患者在患病十年及以后面临哪些问题?来自 NPF-QII 研究的数据。
Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S10-4. doi: 10.1016/j.parkreldis.2012.06.014. Epub 2012 Jul 7.
9
Predictors of clinically meaningful change in PDQ-39 in Parkinson's disease.帕金森病 PDQ-39 中临床有意义变化的预测因素。
Parkinsonism Relat Disord. 2018 Nov;56:93-97. doi: 10.1016/j.parkreldis.2018.06.034. Epub 2018 Jul 2.
10
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.五个欧洲国家中存在运动波动和异动症的帕金森病患者的生活质量
Parkinsonism Relat Disord. 2014 Sep;20(9):969-74. doi: 10.1016/j.parkreldis.2014.06.001. Epub 2014 Jun 10.

引用本文的文献

1
Efficacy and safety of GLP-1 agonists in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.胰高血糖素样肽-1受体激动剂在帕金森病中的疗效与安全性:随机对照试验的系统评价和荟萃分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 11. doi: 10.1007/s00210-025-03932-3.
2
Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review.帕金森病、进行性核上性麻痹和多系统萎缩中与健康相关生活质量评估量表的系统评价
Front Psychol. 2024 Sep 10;15:1438830. doi: 10.3389/fpsyg.2024.1438830. eCollection 2024.
3
Unravelling the mechanisms of underweight in Parkinson's disease by investigating into the role of gut microbiome.通过研究肠道微生物群的作用来揭示帕金森病体重不足的机制。
NPJ Parkinsons Dis. 2024 Jan 24;10(1):28. doi: 10.1038/s41531-023-00587-w.
4
Impact of weight loss for depressive symptom in mid-stage patients with Parkinson's disease: a 4-year follow-up study.体重减轻对帕金森病中期患者抑郁症状的影响:一项4年随访研究
Front Neurol. 2024 Jan 5;14:1306138. doi: 10.3389/fneur.2023.1306138. eCollection 2023.
5
Weight and survival after deep brain stimulation for Parkinson's disease.脑深部电刺激治疗帕金森病术后的体重与生存。
Parkinsonism Relat Disord. 2023 Oct;115:105810. doi: 10.1016/j.parkreldis.2023.105810. Epub 2023 Aug 18.
6
Impaired skeletal muscle health in Parkinsonian syndromes: clinical implications, mechanisms and potential treatments.帕金森综合征中骨骼肌健康受损:临床意义、机制及潜在治疗方法
J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):1987-2002. doi: 10.1002/jcsm.13312. Epub 2023 Aug 13.
7
Machine-learning prediction of BMI change among doctors and nurses in North China during the COVID-19 pandemic.新冠疫情期间中国北方医生和护士体重指数变化的机器学习预测
Front Nutr. 2023 Jan 26;10:1019827. doi: 10.3389/fnut.2023.1019827. eCollection 2023.
8
Parkinson's Disease and Sugar Intake-Reasons for and Consequences of a Still Unclear Craving.帕金森病与糖摄入量:一种尚未明确的渴望的原因和后果。
Nutrients. 2022 Aug 8;14(15):3240. doi: 10.3390/nu14153240.
9
The Deficiency of SCARB2/LIMP-2 Impairs Metabolism via Disrupted mTORC1-Dependent Mitochondrial OXPHOS.SCARB2/LIMP-2 缺乏通过破坏 mTORC1 依赖性线粒体 OXPHOS 来影响代谢。
Int J Mol Sci. 2022 Aug 3;23(15):8634. doi: 10.3390/ijms23158634.
10
Clinical trajectories and biomarkers for weight variability in early Parkinson's disease.早期帕金森病体重变化的临床轨迹和生物标志物
NPJ Parkinsons Dis. 2022 Aug 2;8(1):95. doi: 10.1038/s41531-022-00362-3.

本文引用的文献

1
Major nutritional issues in the management of Parkinson's disease.帕金森病管理中的主要营养问题。
Mov Disord. 2009 Oct 15;24(13):1881-92. doi: 10.1002/mds.22705.
2
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.帕金森病的非运动症状:多巴胺能病理生理学与治疗
Lancet Neurol. 2009 May;8(5):464-74. doi: 10.1016/S1474-4422(09)70068-7.
3
Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients.帕金森病患者的每日能量消耗、身体活动及体重减轻情况
Mov Disord. 2009 Apr 15;24(5):667-71. doi: 10.1002/mds.22372.
4
Neural control of the gastrointestinal tract: implications for Parkinson disease.胃肠道的神经控制:对帕金森病的影响。
Mov Disord. 2008 Jun 15;23(8):1065-75. doi: 10.1002/mds.22051.
5
Association of olfactory dysfunction with risk for future Parkinson's disease.嗅觉功能障碍与未来帕金森病风险的关联。
Ann Neurol. 2008 Feb;63(2):167-73. doi: 10.1002/ana.21291.
6
Body weight in patients with Parkinson's disease.帕金森病患者的体重
Mov Disord. 2006 Nov;21(11):1824-30. doi: 10.1002/mds.21068.
7
Food habits and intake of nutrients in elderly patients with Parkinson's disease.帕金森病老年患者的饮食习惯和营养摄入情况
Gerontology. 2006;52(3):160-8. doi: 10.1159/000091825.
8
Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) [RETIRED]: report of the Quality Standards Subcommittee of the American Academy of Neurology.实践参数:新发帕金森病的诊断与预后(循证综述)[已退休]:美国神经病学学会质量标准小组委员会报告
Neurology. 2006 Apr 11;66(7):968-75. doi: 10.1212/01.wnl.0000215437.80053.d0.
9
Predictors of weight loss in Parkinson's disease.帕金森病体重减轻的预测因素。
Mov Disord. 2006 Jul;21(7):930-6. doi: 10.1002/mds.20837.
10
Compulsive eating and weight gain related to dopamine agonist use.与多巴胺激动剂使用相关的强迫性进食和体重增加。
Mov Disord. 2006 Apr;21(4):524-9. doi: 10.1002/mds.20757.